Skip to content

xAI: Musk startet Grokipedia

Das KI-Unternehmen xAI von Elon Musk hat am 27. Oktober 2025 die Beta-Version 0.1 von Grokipedia online gestellt. Die Plattform positioniert sich als unvoreingenommene Alternative zu Wikipedia und umfasst über 800.000 Artikel. Der Launch erfolgte nach mehreren Verzögerungen, die Musk auf die Notwendigkeit zurückführte, „Propaganda“ aus dem Wissenssystem zu entfernen. Grokipedia nutzt KI-Modelle wie Grok,…

xAI lanciert Grokipedia als KI-gestützte Wikipedia-Alternative
author avatar
LabNews Media LLC
The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They are bestselling authors, science writers and science journalists since 1994.More details about their writing on X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
See Full Bio
LabNews Media LLC

LabNews Media LLC

The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They have been bestselling authors, science writers, and science journalists since 1994.More details about their writing at X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu

Similar Posts

CDC Revises Website: No Evidence Against Vaccine-Autism Link – Scientists Warn of Misinformation

The U.S. Centers for Disease Control and Prevention (CDC) fundamentally changed its vaccine safety website on November 19, 2025. The previous clear statement…

more »CDC Revises Website: No Evidence Against Vaccine-Autism Link – Scientists Warn of Misinformation

Pharma Giants Strengthen US Production: Novartis and Moderna Invest Billions in New Facilities

Amid increasing uncertainties due to possible tariffs and trade conflicts, large pharmaceutical companies are focusing on stronger anchoring in the USA. Novartis and Moderna have recently made extensive 

more »Pharma giants strengthen US production: Novartis and Moderna invest billions in new facilities

Skin-permeable polymer enables needle-free insulin delivery through the skin

A newly developed polymer can penetrate intact skin and deliver large molecules such as insulin into the bloodstream without a syringe or microneedles. Chinese researchers report in 

more »Skin-permeable polymer enables needle-free insulin delivery through the skin